SH2B3
Basic information
Region (hg38): 12:111405922-111451623
Links
Phenotypes
GenCC
Source:
- primary familial polycythemia due to EPO receptor mutation (No Known Disease Relationship), mode of inheritance: Unknown
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
- thrombocythemia 1 (No Known Disease Relationship), mode of inheritance: Unknown
- growth retardation-mild developmental delay-chronic hepatitis syndrome (Supportive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (27 variants)
- Inborn genetic diseases (23 variants)
- not specified (14 variants)
- SH2B3-related condition (3 variants)
- Thrombocythemia 1 (3 variants)
- Primary familial polycythemia due to EPO receptor mutation (3 variants)
- Primary myelofibrosis;Thrombocythemia 1;Primary familial polycythemia due to EPO receptor mutation (1 variants)
- Primary myelofibrosis (1 variants)
- Hereditary cancer (1 variants)
- Thrombocythemia 1;Primary familial polycythemia due to EPO receptor mutation;Primary myelofibrosis (1 variants)
- Hereditary cancer-predisposing syndrome (1 variants)
- Familial myelofibrosis (1 variants)
- Developmental and epileptic encephalopathy, 67 (1 variants)
- Hepatoblastoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH2B3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 32 | 42 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 12 | |||||
Total | 2 | 1 | 36 | 5 | 18 |
Highest pathogenic variant AF is 0.00000658
Variants in SH2B3
This is a list of pathogenic ClinVar variants found in the SH2B3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-111406282-G-A | Likely benign (-) | |||
12-111417874-A-G | Benign (Feb 28, 2019) | |||
12-111418146-A-G | Primary familial polycythemia due to EPO receptor mutation | Pathogenic (May 04, 2022) | ||
12-111418234-G-A | Familial myelofibrosis | Uncertain significance (-) | ||
12-111418248-G-T | Inborn genetic diseases | Uncertain significance (Aug 01, 2022) | ||
12-111418257-G-A | not specified | Benign (May 04, 2022) | ||
12-111418276-A-G | Inborn genetic diseases | Uncertain significance (Nov 09, 2021) | ||
12-111418294-G-T | Inborn genetic diseases | Uncertain significance (Jun 29, 2022) | ||
12-111418301-T-G | Inborn genetic diseases | Uncertain significance (Feb 06, 2023) | ||
12-111418317-C-G | Inborn genetic diseases | Uncertain significance (Sep 26, 2022) | ||
12-111418375-G-A | not specified | Uncertain significance (May 04, 2022) | ||
12-111418377-G-A | SH2B3-related disorder | Likely benign (May 07, 2020) | ||
12-111418478-C-T | Likely benign (Dec 31, 2019) | |||
12-111418485-G-T | Inborn genetic diseases | Uncertain significance (Jun 23, 2023) | ||
12-111418569-C-T | Uncertain significance (Dec 02, 2020) | |||
12-111418594-C-A | Uncertain significance (Aug 01, 2021) | |||
12-111418609-C-T | not specified • Thrombocythemia 1 | Uncertain significance (Dec 14, 2022) | ||
12-111418627-C-T | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (-) | ||
12-111418639-C-G | not specified • SH2B3-related disorder | Benign (May 09, 2023) | ||
12-111418685-G-A | not specified | Benign (Nov 26, 2021) | ||
12-111418689-T-C | SH2B3-related disorder | Benign (May 09, 2023) | ||
12-111418702-G-T | Likely benign (Mar 01, 2024) | |||
12-111418744-TGCTGC-T | Primary myelofibrosis | Pathogenic (Aug 12, 2010) | ||
12-111418750-G-C | Inborn genetic diseases | Uncertain significance (Nov 21, 2022) | ||
12-111418767-G-C | Thrombocythemia 1 • Developmental and epileptic encephalopathy, 67 • Hepatoblastoma • Primary myelofibrosis | Conflicting classifications of pathogenicity (May 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH2B3 | protein_coding | protein_coding | ENST00000341259 | 7 | 45676 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000103 | 0.989 | 125720 | 0 | 27 | 125747 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.415 | 301 | 322 | 0.935 | 0.0000233 | 3559 |
Missense in Polyphen | 122 | 138.12 | 0.88326 | 1508 | ||
Synonymous | 1.93 | 120 | 150 | 0.800 | 0.0000116 | 1259 |
Loss of Function | 2.24 | 10 | 21.1 | 0.473 | 0.00000115 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000243 | 0.000243 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000941 | 0.0000924 |
European (Non-Finnish) | 0.000100 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000136 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Links T-cell receptor activation signal to phospholipase C-gamma-1, GRB2 and phosphatidylinositol 3-kinase. {ECO:0000250}.;
- Disease
- DISEASE: Celiac disease 13 (CELIAC13) [MIM:612011]: A multifactorial, chronic disorder of the small intestine caused by intolerance to gluten. It is characterized by immune-mediated enteropathy associated with failed intestinal absorption, and malnutrition. In predisposed individuals, the ingestion of gluten- containing food such as wheat and rye induces a flat jejunal mucosa with infiltration of lymphocytes. {ECO:0000269|PubMed:18311140}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, insulin-dependent (IDDM) [MIM:222100]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:17554260}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Neurotrophin signaling pathway - Homo sapiens (human);TYROBP Causal Network;T-Cell antigen Receptor (TCR) Signaling Pathway;Signal Transduction;Factors involved in megakaryocyte development and platelet production;TCR;Regulation of KIT signaling;Hemostasis;EPO signaling pathway;Signaling by SCF-KIT;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by Stem cell factor receptor (c-Kit)
(Consensus)
Recessive Scores
- pRec
- 0.358
Haploinsufficiency Scores
- pHI
- 0.782
- hipred
- Y
- hipred_score
- 0.552
- ghis
- 0.430
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.679
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sh2b3
- Phenotype
- cellular phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;positive regulation of signal transduction;cell differentiation;embryonic hemopoiesis;intracellular signal transduction
- Cellular component
- cytosol;plasma membrane
- Molecular function
- transmembrane receptor protein tyrosine kinase adaptor activity;protein binding